Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caffeine and schizophrenia

J R Hughes1, P McHugh, S Holtzman

  • 1Department of Psychiatry, Psychology, and Family Practice at the University of Vermont, Burlington 05401-1419, USA. john.hughes@uvm.edu

Psychiatric Services (Washington, D.C.)
|November 24, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How does methamphetamine affect the brain? A systematic review of magnetic resonance imaging studies.

Drug and alcohol dependence·2025
Same author

'Show me the money': improving the economic evaluation of mental health services.

Irish journal of psychological medicine·2018
Same author

An evaluation of Access to Psychological Services Ireland: year one outcomes.

Irish journal of psychological medicine·2018
Same author

Electro-mechanical response of a 3D nerve bundle model to mechanical loads leading to axonal injury.

International journal for numerical methods in biomedical engineering·2017
Same author

Electro-mechanical response of a 3D nerve bundle model to mechanical loads leading to axonal injury.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2017
Same author

Complications following laryngeal sacculectomy in brachycephalic dogs.

The Journal of small animal practice·2017
Same journal

Unanticipated Effects of Parental Social Media Use: Guidance for Clinicians.

Psychiatric services (Washington, D.C.)·2026
Same journal

Learning About Stigma From Inside the Classroom.

Psychiatric services (Washington, D.C.)·2026
Same journal

Characteristics of Clinical Supervision Associated With Improvements in Youth Outcomes in Community Mental Health Clinics.

Psychiatric services (Washington, D.C.)·2026
Same journal

VA Health Care Utilization Among U.S. Veterans: The Influence of Social Determinants of Health and Health Factors.

Psychiatric services (Washington, D.C.)·2026
Same journal

Defining Digital Peer Support: A Framework to Preserve Core Values in the Rush to Digitize.

Psychiatric services (Washington, D.C.)·2026
Same journal

Perspectives of Individuals With Lived Experience on Obsessive-Compulsive Disorder Treatment Delivery, Supports, and Research.

Psychiatric services (Washington, D.C.)·2026
See all related articles

Patients with schizophrenia often consume high amounts of caffeine, but its effects remain unclear. Research suggests caffeine may influence dopamine, potentially impacting schizophrenia symptoms, though clinical outcomes show no significant change upon caffeine elimination.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Patients with schizophrenia exhibit high caffeine intake, with underlying reasons yet to be elucidated.
  • Caffeine's known dopaminergic effects in nonhumans suggest potential impacts on schizophrenia symptoms and tardive dyskinesia.

Purpose of the Study:

  • To explore the relationship between caffeine consumption and schizophrenia.
  • To investigate the potential effects of caffeine on schizophrenia symptoms, neuroleptic efficacy, and patient response.

Main Methods:

  • Review of existing data on caffeine intake in schizophrenia patients.
  • Analysis of pharmacological interactions between caffeine, dopamine, and antipsychotic medications.
  • Observation of clinical outcomes in patients with schizophrenia undergoing caffeine elimination or chronic use.

Related Experiment Videos

Main Results:

  • High caffeine intake is observed in patients with schizophrenia, though its clinical significance is uncertain.
  • Caffeine elimination did not result in significant clinical improvement or worsening of schizophrenia symptoms.
  • Schizophrenia patients may exhibit reduced anxiety responses to high caffeine doses compared to the general population.

Conclusions:

  • The clinical impact of high caffeine consumption in schizophrenia remains largely undetermined.
  • Further research is needed to understand caffeine's interaction with clozapine and its overall effect on schizophrenia management.